{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:01Z","timestamp":1792099561489,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101150"],"award-info":[{"award-number":["82101150"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171078"],"award-info":[{"award-number":["82171078"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870670"],"award-info":[{"award-number":["81870670"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR2041B"],"award-info":[{"award-number":["SHDC2020CR2041B"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR5014-003"],"award-info":[{"award-number":["SHDC2020CR5014-003"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shanghai Sailing Program","award":["21YF1405300"],"award-info":[{"award-number":["21YF1405300"]}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["20Y11911100"],"award-info":[{"award-number":["20Y11911100"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","award":["18411965100"],"award-info":[{"award-number":["18411965100"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40123-022-00588-7","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T08:03:03Z","timestamp":1665561783000},"page":"2309-2320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Three Monthly Injections Versus One Initial Injection of Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion: 12-Month Results of a Prospective Randomized Study"],"prefix":"10.1007","volume":"11","clinical-trial-number":[{"clinical-trial-number":"chictr2000038086","registry":"10.18810\/chictr"}],"author":[{"given":"Wenyi","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gezhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-4722","authenticated-orcid":false,"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"588_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009510.pub2","author":"D Mitry","year":"2013","unstructured":"Mitry D, Bunce C, Charteris D. Anti-vascular endothelial growth factor for macular edema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD009510.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1102\u201312","key":"588_CR2","volume":"117","author":"PA Campochiaro","year":"2010","unstructured":"Campochiaro PA, Heier JS, Feiner L, et\u00a0al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117(1102\u201312): e1.","journal-title":"Ophthalmology"},{"key":"588_CR3","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","volume":"118","author":"DM Brown","year":"2011","unstructured":"Brown DM, Campochiaro PA, Bhisitkul RB, et\u00a0al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology. 2011;118:1594\u2013602.","journal-title":"Ophthalmology"},{"key":"588_CR4","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2016.02.030","volume":"123","author":"R Tadayoni","year":"2016","unstructured":"Tadayoni R, Waldstein SM, Boscia F, et\u00a0al. Individualized stabilization criteria-driven ranibizumab versus laser in branch retinal vein occlusion: six-month results of brighter. Ophthalmology. 2016;123:1332\u201344.","journal-title":"Ophthalmology"},{"key":"588_CR5","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1097\/IAE.0000000000000111","volume":"34","author":"T Brynskov","year":"2014","unstructured":"Brynskov T, Kemp H, Sorensen TL. Intravitreal ranibizumab for retinal vein occlusion through 1 year in clinical practice. Retina. 2014;34:1637\u201343.","journal-title":"Retina"},{"key":"588_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2147\/OPTH.S29075","volume":"6","author":"AM Mansour","year":"2012","unstructured":"Mansour AM, Shahin M, Kofoed PK, et\u00a0al. Insight into 144 patients with ocular vascular events during VEGF antagonist injections. Clin Ophthalmol. 2012;6:343\u201363.","journal-title":"Clin Ophthalmol"},{"key":"588_CR7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","volume":"27","author":"KG Falavarjani","year":"2013","unstructured":"Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond). 2013;27:787\u201394.","journal-title":"Eye (Lond)"},{"key":"588_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/bjophthalmol-2014-306543","volume":"99","author":"R Narayanan","year":"2015","unstructured":"Narayanan R, Panchal B, Das T, et\u00a0al. A randomized, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular edema due to branch retinal vein occlusion: MARVEL Report No. 1. Br J Ophthalmol. 2015;99:954\u20139.","journal-title":"Br J Ophthalmol"},{"key":"588_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/IAE.0000000000001224","volume":"37","author":"Y Miwa","year":"2017","unstructured":"Miwa Y, Muraoka Y, Osaka R, et\u00a0al. Ranibizumab for macular edema after branch retinal vein occlusion: one initial injection versus three monthly injections. Retina. 2017;37:702\u20139.","journal-title":"Retina"},{"key":"588_CR10","first-page":"1534","volume":"11","author":"AH Bayat","year":"2018","unstructured":"Bayat AH, Cakir A, Ozturan SG, et\u00a0al. Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion. Int J Ophthalmol. 2018;11:1534\u20138.","journal-title":"Int J Ophthalmol"},{"key":"588_CR11","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1007\/s00417-021-05150-y","volume":"259","author":"DG Park","year":"2021","unstructured":"Park DG, Jeong WJ, Park JM, et\u00a0al. Prospective trial of treat-and-extend regimen with aflibercept for branch retinal vein occlusion: 1-year results of the PLATON trial. Graefes Arch Clin Exp Ophthalmol. 2021;259:2879\u201386.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"588_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00417-020-04639-2","volume":"258","author":"L Su","year":"2020","unstructured":"Su L, Ji YS, Tong N, et\u00a0al. Quantitative assessment of the retinal microvasculature and choriocapillaris in myopic patients using swept-source optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2020;258:1173\u201380.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"588_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.oret.2019.08.001","volume":"4","author":"W Wei","year":"2020","unstructured":"Wei W, Weisberger A, Zhu L, et\u00a0al. Efficacy and safety of ranibizumab in Asian patients with branch retinal vein occlusion: results from the randomized BLOSSOM study. Ophthalmol Retina. 2020;4:57\u201366.","journal-title":"Ophthalmol Retina"},{"key":"588_CR14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/OPTH.S76261","volume":"9","author":"Y Ito","year":"2015","unstructured":"Ito Y, Saishin Y, Sawada O, et\u00a0al. Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion. Clin Ophthalmol. 2015;9:175\u201380.","journal-title":"Clin Ophthalmol"},{"key":"588_CR15","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/IAE.0000000000001334","volume":"37","author":"A Sellam","year":"2017","unstructured":"Sellam A, Glacet-Bernard A, Coscas F, et\u00a0al. Qualitative and quantitative follow-up using optical coherence tomography angiography of retinal vein occlusion treated with anti-VEGF: optical coherence tomography angiography follow-up of retinal vein occlusion. Retina. 2017;37:1176\u201384.","journal-title":"Retina"},{"key":"588_CR16","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1007\/s00417-019-04371-6","volume":"257","author":"K Tsuboi","year":"2019","unstructured":"Tsuboi K, Kamei M. Longitudinal vasculature changes in branch retinal vein occlusion with projection-resolved optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2019;257:1831\u201340.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"588_CR17","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2147\/OPTH.S107594","volume":"10","author":"Y Sakanishi","year":"2016","unstructured":"Sakanishi Y, Lee A, Usui-Ouchi A, et\u00a0al. Twelve-month outcomes in patients with retinal vein occlusion treated with low-frequency intravitreal ranibizumab. Clin Ophthalmol. 2016;10:1161\u20135.","journal-title":"Clin Ophthalmol"},{"key":"588_CR18","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1097\/IAE.0000000000002571","volume":"40","author":"M Khayat","year":"2020","unstructured":"Khayat M, Wright DM, Yeong J, et\u00a0al. Impact of retinal ischemia on functional and anatomical outcomes after anti-vascular endothelial growth factor therapy in patients with retinal vein occlusion. Retina. 2020;40:1098\u2013109.","journal-title":"Retina"},{"key":"588_CR19","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/S0161-6420(79)35327-1","volume":"86","author":"H Zegarra","year":"1979","unstructured":"Zegarra H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology. 1979;86:1931\u201342.","journal-title":"Ophthalmology"},{"key":"588_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000310354","volume":"206","author":"SS Hayreh","year":"1993","unstructured":"Hayreh SS, Rubenstein L, Podhajsky P. Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion A prospective clinical trial. Ophthalmologica. 1993;206:1\u201314.","journal-title":"Ophthalmologica"},{"key":"588_CR21","doi-asserted-by":"crossref","unstructured":"Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol. 1986;104:34\u201341.","DOI":"10.1001\/archopht.1986.01050130044017"},{"key":"588_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.oret.2021.11.003","volume":"6","author":"H Takatsu","year":"2022","unstructured":"Takatsu H, Tsuboi K, Wakabayashi T, et\u00a0al. Vascular abnormalities may progress in branch vein occlusion despite resolution of macular edema. Ophthalmol Retina. 2022;6:252\u20134.","journal-title":"Ophthalmol Retina"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-022-00588-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-022-00588-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T10:30:47Z","timestamp":1666348247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-022-00588-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1007\/s40123-022-00588-7","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}